| | 55268-75-2 Basic information More.. |
| Product Name: | Cefuroxime | | Synonyms: | Cefuroxime VETRANAL;5-Thia-1-azabicyclo4.2.0oct-2-ene-2-carboxylic acid, 3-(aminocarbonyl)oxymethyl-7-(2Z)-2-furanyl(methoxyimino)acetylamino-8-oxo-, (6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-[[2-furanyl(methoxyimino)acetyl]amino]-8-oxo-, [6R-[6α,7β(Z)]]-;Biofuroksym;Cephuroxime;Ketocef;(6r-(6-alpha,7-beta(zethyl)-7-((2- furanyl(methyoxyimino)acetyl)amino)-8-oxo-;Cefuroxime | | CAS: | 55268-75-2 | | MF: | C16H16N4O8S | | MW: | 424.39 | | EINECS: | 259-560-1 | | Mol File: | 55268-75-2.mol |  |
Use
Cefuroxime axetil (Ceftin) is the 1-acetyoxyethyl ester ofcefuroxime. During absorption, this acid-stable, lipophilic,oral prodrug derivative of cefuroxime is hydrolyzed to cefuroximeby intestinal and/or plasma enzymes. The axetilester provides an oral bioavailability of 35% to 50% of cefuroxime,depending on conditions. Oral absorption of theester is increased by food but decreased by antacids and histamineH2-antagonists. The latter effect may be because ofspontaneous hydrolysis of the ester in the intestine becauseof the higher pH created by these drugs. Axetil is used forthe oral treatment of non–life-threatening infections causedby bacteria that are susceptible to cefuroxime. The prodrugform permits twice-a-day dosing for such infections.
- Cefuroxime
-
- 2025-08-10
- CAS:55268-75-2
- Min. Order:
- Purity: 0.99
- Supply Ability:
- Cefuroxime
-
- US $0.00-0.00 / Kg/Drum
- 2025-08-08
- CAS:55268-75-2
- Min. Order: 1KG
- Purity: 98%min
- Supply Ability: 500kg
- Cefuroxim
-
- US $0.00 / KG
- 2025-08-08
- CAS:55268-75-2
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
|
|
55268-75-2
Recommend Suppliers |
|